Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management

Journal of Clinical Oncology

Volumn 27, Issue 26, 2009, Pages 4321-4326

  Onik, Gary ^a   Miessau, Matthew ^a   Bostwick, David G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; REDUCTASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BLADDER IRRIGATION; BRACHYTHERAPY; CANCER PATIENT; CANCER STAGING; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HEMATURIA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; THREE DIMENSIONAL IMAGING; TRANSRECTAL ULTRASONOGRAPHY; BIOPSY; METHODOLOGY; PATHOLOGY; PROGNOSIS; PROSTATE; PROSTATE TUMOR; REPRODUCIBILITY; STATISTICS;

BIOPSY; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; NEOPLASM STAGING; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 70349321503     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.20.3497     Document Type: Article

References (16)

1. Epstein JI, Sanderson H, Carter HB, et al: Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy. Urology 66:356-360, 2005
2. Khaksar SJ, Langley SE, Lovell D, et al: Interstitial low dose rate brachytherapy for prostate cancer: A focus on intermediate- and high-risk disease. Clin Oncol (R Coll Radiol) 18:513-518, 2006
3. D'Amico AV, Chen MH, Renshaw AA, et al: Androgen suppression and radiation vs radiation alone for prostate cancer: A randomized trial. JAMA 299:289-295, 2008
4. Eggener SE, Scardino PT, Carroll PR, et al: Focal therapy for localized prostate cancer: A critical appraisal of rationale and modalities. J Urol 178: 2260-2267, 2007
5. Westphalen AC, Coakley FV, Qayyum A, et al: Peripheral zone prostate cancer: Accuracy of different interpretative approaches with MR and MR spectroscopic imaging. Radiology 246:177-184, 2008
6. Bulbul MA, El-Hout Y, Haddad M, et al: Pathological correlation between needle biopsy and radical prostatectomy specimen in patients with localized prostate cancer. Can Urol Assoc J 1:264-266, 2007
7. Barzell WE, Melamed MR: Appropriate patient selection in the focal treatment of prostate cancer: The role of transperineal 3-dimensional pathologic mapping of the prostate - A 4-year experience. Urology 70:27-35, 2007 (suppl 6)
8. Barzell WE, Whitmore WF: Transperineal template guided saturation biopsy of the prostate: Rational, indications and technique. Urol Times 32: 41-42, 2003
9. Crawford ED, Wilson SS, Torkko KC, et al: Clinical staging of prostate cancer: A computersimulated study of transperineal prostate biopsy. BJU Int 96:999-1004, 2005
10. O'Donnell H, Parker C: What is low-risk prostate cancer and what is its natural history? World J Urol 26:415-422, 2008
11. Wallace M: Uncertainty and quality of life of older men who undergo watchful waiting for prostate cancer. Oncol Nurs Forum 30:303-309, 2003
12. Hedestig O, Sandman PO, Widmark A: Living with untreated localized prostate cancer: A qualitative analysis of patient narratives. Cancer Nurs 26: 55-60, 2003
13. Boccon-Gibod LM, de Longchamps NB, Toublanc M, et al: Prostate saturation biopsy in the reevaluation of microfocal prostate cancer. J Urol 176:961-963, 2006
14. Bostwick DG, Onik GM: Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006. Urology 70:42-44, 2007 (suppl 6)
15. Partin AW, Yoo J, Carter HB, et al: The use of prostate specific antigen, clinical stage, and Gleason Score to predict pathological stage in men with localized prostate cancer. J Urol 150:110-114, 1993
16. Partin AW, Mangold LA, Lamm DM, et al: Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 58:843-848, 2001